Pharmagest Interactive | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
113,407.00
114,560.00
113,477.00
128,381.00
146,806.00
148,480
Cost of Goods Sold (COGS) incl. D&A
88,527.00
86,871.00
79,499.00
90,485.00
109,218.00
106,469
Gross Income
24,880.00
27,689.00
33,978.00
37,896.00
37,588.00
42,011
EBIT
22,338.00
25,229.00
27,951.00
31,386.00
34,521.00
38,916
Unusual Expense
6.00
1.00
4.00
-
-
-
Non Operating Income/Expense
822.00
285.00
383.00
157.00
807.00
1,300
Interest Expense
150.00
159.00
159.00
110.00
218.00
294
Pretax Income
24,164.00
26,492.00
29,312.00
32,524.00
35,110.00
39,922
Income Tax
8,506.00
9,392.00
10,274.00
10,948.00
10,745.00
12,722
Equity in Affiliates
174.00
135.00
42.00
112.00
114.00
162
Consolidated Net Income
15,832.00
16,965.00
18,996.00
21,464.00
24,251.00
27,038
Net Income
15,825.00
17,011.00
18,792.00
20,567.00
23,135.00
25,432
Net Income After Extraordinaries
15,825.00
17,011.00
18,792.00
20,567.00
23,135.00
25,432
Net Income Available to Common
15,825.00
17,011.00
18,792.00
20,567.00
23,135.00
25,432
EPS (Basic)
1.04
1.14
1.25
1.37
1.55
1.70
Basic Shares Outstanding
15,170.00
14,975.90
14,975.80
14,972.10
14,948.90
14,968.60
EPS (Diluted)
1.04
1.12
1.24
1.36
1.55
1.70
Diluted Shares Outstanding
15,170.00
15,215.40
15,174.10
15,174.10
14,948.90
14,968.60
EBITDA
25,162.00
27,748.00
30,908.00
34,854.00
38,757.00
44,121
Other Operating Expense
2,542.00
2,460.00
2,359.00
2,795.00
3,067.00
3,095
Non-Operating Interest Income
1,160.00
1,138.00
1,133.00
1,091.00
-
-
Minority Interest Expense
7.00
46.00
204.00
897.00
1,116.00
1,606
About Pharmagest Interactive
View Profile
